LISA CLAIRMONT: Open Payments
NPI 1174611370 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,244 in 100 payments from 30 companies in 2025. Trend: 2023 $5,297 · 2024 $2,032 · 2025 $2,244
Food & beverage: $2,244
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 11 | $497 |
| Eisai Inc. | 5 | $348 |
| ABBVIE INC. | 22 | $304 |
| EMD Serono, Inc. | 7 | $180 |
| PFIZER INC. | 14 | $152 |
| Janssen Biotech, Inc. | 4 | $71 |
| Novartis Pharmaceuticals Corporation | 4 | $66 |
| Lundbeck LLC | 2 | $61 |
| Radius Health, Inc. | 2 | $49 |
| Celgene Corporation | 2 | $41 |
Products named: Leqembi, VUMERITY, TYSABRI, QULIPTA, NURTEC ODT, BOTOX, TREMFYA, VYEPTI.
Industry payments across ND — which companies pay providers there.
